Bevespi Aerosphere is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — TEVA PHARMS USA INC, approved 2026-04-23 (ANDA212212).
111,454 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.